CClinicalTrials.gg
Status unknownNCT04203992Updated Sep 16, 2020

Videogame for the Prevention of Doping and Supplement Abuse in Teenage Athletes

An interventional study of Videogame and Control in Doping in Sport and Performance Enhancing Product Use, sponsored by McGill University. Status unknown. Open to participants aged 13 Years to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-09-16.

Sponsored by McGill University · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Sep 2020), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
284
Allocation
Non-randomized
Ages
13 Years to 16 Years
Sex
All
01

Study summary

The purpose of this research is to test the effectiveness of an interactive doping education videogame among student athletes. Specifically, the game will teach athletes aged 13-16 years about the risks of doping and will foster the values, motivation, and behavioural skills needed to avoid temptation and pressure to dope. The investigators hypothesize that student athletes who play the intervention game will have lower use of banned substances and sport supplements, greater intentions to stay clean, and will also show improvements in the cognitive and motivational antecedents to doping when compared to a control condition.

Read the detailed description

284 student athletes will be enrolled in this two-arm quasi-experimental study. The participants will be boys and girls, aged 13 to 16 years who compete in any sport. Participants will be recruited and enrolled through partnerships with their school physical education and/or sport programs. Participants will complete baseline questionnaires assessing demographics, history of sport participation, and psychological variables related to doping prevention including knowledge, doping self-regulatory efficacy, motivation, attitudes, intentions, perceived norms, doping refusal, substance use behaviours, and doping related protective behaviours (e.g., checking the list of ingredients on medications). Participants will then be assigned to either an intervention group (n = 142; the doping videogame the investigators are developing) or a comparison group (n = 142). The comparison group will be given printed educational materials about doping education, developed by an accredited source (e.g., UNESCO). Assignment to the intervention or comparison group will be conducted at the level of the school to reduce the potential for contamination that could occur if intervention and comparison students were interacting in their school environment and sharing information they learned from the game. Participants from the intervention group will play five, 60-minute sessions over the course of one month (5 hours of total gameplay). Before the gameplay sessions begin, the Project Director and research assistants will orient the intervention group participants to the use of the intervention videogame. Players will be given a tutorial on an iPad demonstrating the mechanics of the game and how to use the iPad. Each player will have their own dedicated iPad that they will use during each game play session (this will be provided by the research team). Shortly after the last gameplay session is completed, participants from both groups will be asked to complete a questionnaire assessing the same psychological variables assessed at baseline as well as their gameplay experience. The psychological variables will also be assessed at three, six, and 12 month follow-ups.

02

Conditions studied

  • Doping in Sport
  • Performance Enhancing Product Use

Keywords

  • Student athletes
  • Supplements
  • Videogame
03

In context

Lead sponsor

McGill University is the lead sponsor of 244 studies on the registry; 49 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Subject competes in a competitive sport at the high school level or higher
  • Able to read and understand English

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
284 participants (estimated)

Study arms

  • Experimental
    Videogame

    Educational videogame, five 60-minute sessions over one month

    Behavioral: Videogame

  • Active comparator
    Booklet

    Educational booklet, one session

    Behavioral: Control

Interventions

  • BehavioralVideogame

    True Champion is an educational, values-based game that aims to empower young athletes to make informed decisions to avoid doping. Participants engaging in the videogame sessions will encounter a series of thought-provoking situations and knowledge tests. Players will help their assigned character navigate through these curriculum-rich scenarios in order to reach their performance goals in a healthy and ethical way.

  • BehavioralControl

    Participants will be given an anti-doping booklet prepared by UNESCO. This booklet is considered standard educational material, i.e. what might be presented to young athletes as part of their regular sports curriculum.

06

What researchers measure

Primary outcomes

  1. Use of banned substances

    Self-reported use of banned substances for performance enhancement or recovery in sport. This outcome will be measured using a self-reported questionnaire. Scale: Performance-Enhancing Substances and Methods Use Minimum value: 1 - extremely unlikely (better outcome) Maximum value: 7 - extremely likely (worse outcome)

    Time frame: 12 months

  2. Use of sport supplements

    Self-reported use of supplements for performance enhancement or recovery in sport. This outcome will be measured using a self-reported questionnaire. Scale: Performance-Enhancing Substances and Methods Use Minimum value: 1 - extremely unlikely (better outcome) Maximum value: 7 - extremely likely (worse outcome)

    Time frame: 12 months

  3. Intentions to use banned substances and sport supplements

    Self-reported intentions of using banned substances or supplements for performance enhancement or recovery in sport. This outcome will be measured using a self-reported questionnaire. Scale: Performance-Enhancing Substances and Methods Use Minimum value: 1 - extremely unlikely (better outcome) Maximum value: 7 - extremely likely (worse outcome)

    Time frame: 12 months

Secondary outcomes

  1. Knowledge

    Knowledge of anti-doping rules, definitions and consequences of doping. This outcome will be assessed using a True/False questionnaire.

    Time frame: 12 months

  2. Doping Self-Regulatory Efficacy

    Self-efficacy for refusing doping under a variety of pressure situations. This outcome will be measured using a validated questionnaire. Scale: Doping Self-Regulatory Efficacy Minimum value: 1 - no confidence (better outcome) Maximum value: 5 - complete confidence (worse outcome)

    Time frame: 12 months

  3. Motivation

    Motivations for abstaining from doping. This outcome will be measured using an adaptation of a validated questionnaire. Scale: Treatment Self-Regulation Questionnaire for the Avoidance of Doping in Sport Minimum value: 1 - not true at all (worse outcome) Maximum value: 7 - very true (better outcome)

    Time frame: 12 months

  4. Attitudes

    Attitudes towards doping in sport. This outcome will be measured using a subscale from a validated questionnaire. Scale: The Adolescent Sport Doping Inventory Minimum value: 1 - strongly disagree (worse outcome) Maximum value: 7 - strongly agree (better outcome) Note: some items are reverse-scored

    Time frame: 12 months

  5. Anti-doping protective behaviours

    Self-reported engagement in behaviours linked to doping abstinence. Scale: Microbehaviours Minimum value: 1 - never (worse outcome) Maximum value: 7 - always (better outcome)

    Time frame: 12 months

  6. Doping refusal

    Self-report of having refused a supplement or performance-enhancing substance. This outcome will be assessed using a Yes (worse outcome) or No (better outcome) questionnaire.

    Time frame: 12 months

  7. Gameplay experience

    Enjoyment and acceptability of the True Champion videogame among players assigned to the intervention condition. This outcome will be assessed using a questionnaire we have created. Answers will range from "strongly disagree" to "strongly agree".

    Time frame: 1 month

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Goulet C, Valois P, Buist A, Cote M. Predictors of the use of performance-enhancing substances by young athletes. Clin J Sport Med. 2010 Jul;20(4):243-8. doi: 10.1097/JSM.0b013e3181e0b935. PubMed 20606508 ↗
  • Boardley I, Smith AL, Mills JP, Grix J, Wynne C., & Wilkins L. Development of Moral Disengagement and Self-Regulatory Efficacy Assessments Relevant to Doping in Sport and Exercise. SportRxiv, 12 Oct. 2017. Web.
  • Chan DK, Dimmock JA, Donovan RJ, Hardcastle S, Lentillon-Kaestner V, Hagger MS. Self-determined motivation in sport predicts anti-doping motivation and intention: a perspective from the trans-contextual model. J Sci Med Sport. 2015 May;18(3):315-22. doi: 10.1016/j.jsams.2014.04.001. Epub 2014 Apr 13. PubMed 24793786 ↗
  • Nicholls AR, Levy AR, Meir R, Sanctuary C, Jones L, Baghurst T, Thompson MA, Perry JL. The development and validation of the Adolescent Sport Drug Inventory (ASDI) among athletes from four continents. Psychol Assess. 2019 Nov;31(11):1279-1293. doi: 10.1037/pas0000750. Epub 2019 Jul 18. PubMed 31318254 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 16, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04203992
Lead sponsor
McGill University
Collaborators
International Olympic Committee, World Anti-Doping Agency, Phantom Compass, Digitalmill, Inc.
Responsible party
Lindsay Duncan (Associate Professor, William Dawson Scholar, McGill University) — Principal investigator
First posted
Dec 18, 2019
Start date
Nov 2020 (estimated)
Primary completion
Dec 2021 (estimated)
Completion
Jun 2022 (estimated)
Last update
Sep 16, 2020

Study contacts

Lindsay R Duncan, PhD
Contact
lindsay.duncan@mcgill.ca
514-398-4184 ext. 00919
Evelyne Bedard, MSc
Contact
evelyne.bedard@mcgill.ca
514-398-4814 ext. 09976
Lindsay R Duncan, PhD
principal investigator · McGill University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion